Klingman & Associates LLC Cuts Position in UnitedHealth Group Incorporated $UNH

Klingman & Associates LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the second quarter, HoldingsChannel reports. The fund owned 1,159 shares of the healthcare conglomerate’s stock after selling 147 shares during the quarter. Klingman & Associates LLC’s holdings in UnitedHealth Group were worth $362,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. DekaBank Deutsche Girozentrale grew its stake in UnitedHealth Group by 1.1% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 936,422 shares of the healthcare conglomerate’s stock worth $291,636,000 after buying an additional 10,633 shares during the last quarter. Princeton Global Asset Management LLC grew its stake in UnitedHealth Group by 96.7% during the 2nd quarter. Princeton Global Asset Management LLC now owns 474 shares of the healthcare conglomerate’s stock worth $148,000 after buying an additional 233 shares during the last quarter. Crewe Advisors LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $214,000. Alan B Lancz & Associates Inc. purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $407,000. Finally, Sentry Investment Management LLC grew its stake in UnitedHealth Group by 38.4% during the 2nd quarter. Sentry Investment Management LLC now owns 4,170 shares of the healthcare conglomerate’s stock valued at $1,283,000 after purchasing an additional 1,157 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $365.47 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50 day simple moving average of $333.70 and a 200-day simple moving average of $341.28. The firm has a market capitalization of $331.00 billion, a PE ratio of 15.83, a price-to-earnings-growth ratio of 2.36 and a beta of 0.47. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

Analyst Ratings Changes

Several analysts have weighed in on the company. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.